PRESS RELEASE published on 10/15/2024 at 08:00, 1 year 6 months ago R3 l'opérateur de bornes de recharge de DBT prévoit une multiplication par 2 de son CA 2024 R3 prévoit de doubler son chiffre d'affaires en 2024 en raison de l'augmentation de la consommation d'électricité sur ses bornes de recharge DBT. Le groupe DBT se diversifie avec succès en tant qu'opérateur de bornes rapides Croissance DBT Électrique Recharge R3
PRESS RELEASE published on 10/15/2024 at 08:00, 1 year 6 months ago HOPIUM renforce sa visibilité à l'international en participant au salon Hydrogen Technology Expo Europe Hopium renforce sa visibilité à l'international en participant au salon Hydrogen Technology Expo Europe pour présenter sa technologie de pile à combustible. Objectif : décarboner les transports lourds Technologie Décarbonation HOPIUM Transports Lourds Hydrogen Technology Expo Europe
PRESS RELEASE published on 10/15/2024 at 08:00, 1 year 6 months ago Inside Information / Other news releases OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment
PRESS RELEASE published on 10/15/2024 at 07:33, 1 year 6 months ago ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec ONWARD Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d'interface cerveau machine WIMAGINE de Clinatec, visant à restaurer les mouvements guidés par la pensée après une paralysie Technologie CEA ONWARD Medical Interface Cerveau Machine WIMAGINE
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Atos appoints Philippe Salle Chairman of the Board of Directors with effect from October 14, 2024 and Chairman and Chief Executive Officer from February 01, 2025 Atos appoints Philippe Salle as Chairman of the Board of Directors with immediate effect and Chairman and CEO from February 01, 2025. The appointment follows a rigorous selection process. Salle brings extensive CEO experience to support the business plan and Group restructuring Restructuring Chairman CEO Atos Philippe Salle
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce la fin du recrutement de son essai de Phase 3 ARES pour MaaT013 dans le traitement de la maladie aiguë du greffon contre l'hôte. Premiers résultats attendus en janvier 2025 MaaT Pharma MaaT013 Phase 3 ARES Maladie Aiguë Greffon Contre L'hôte
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Atos nomme Philippe Salle Président du Conseil d’administration à compter du 14 octobre 2024 et Président-Directeur général à compter du 1er février 2025 Atos appoints Philippe Salle Chairman of the Board of Directors with effect from October 14, 2024 and Chairman and Chief Executive Officer from February 01, 2025. Philippe Salle brings extensive CEO experience to support the Group's business plan and restructuring Chairman CEO Financial Restructuring Atos Philippe Salle
REGULATED PRESS RELEASE published on 10/15/2024 at 07:01, 1 year 6 months ago bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration bioMerieux announces CE-marking for VIDAS Vitamin B12 Total, an automated blood test to measure total B12 concentration in serum or plasma, aiding in the assessment of B12 status and optimizing patient care BioMérieux CE-marking VIDAS Vitamin B12 Total Blood Test
REGULATED PRESS RELEASE published on 10/15/2024 at 07:01, 1 year 6 months ago bioMérieux obtient le marquage CE du test sanguin VIDAS® VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12 bioMérieux obtient le marquage CE pour le test sanguin VIDAS VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12, renforçant leur gamme d'immunoessais BioMérieux Marquage CE VIDAS Vitamine B12 Test Sanguin
Published on 05/15/2026 at 00:00, 13 minutes ago Redwood AI Announces Optimization Module Update to Reactosphere, Expanding Experimental Planning and Chemical Process Optimization Capabilities
Published on 05/14/2026 at 23:00, 1 hour 13 minutes ago Route1 Reports Q1 2026 Results and Continued Expansion of Recurring Operational Engagement
Published on 05/14/2026 at 23:00, 1 hour 13 minutes ago CCL Industries Announces Intention to Renew Normal Course Issuer Bid and Automatic Securities Purchase Plan
Published on 05/14/2026 at 22:10, 2 hours 3 minutes ago International Battery Metals Ltd. Announced RSU Grant
Published on 05/14/2026 at 22:05, 2 hours 8 minutes ago GameSquare Holdings Reports 2026 First Quarter Results with Revenue up 95.0% Year-over-Year
Published on 05/15/2026 at 00:05, 8 minutes ago ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds
Published on 05/14/2026 at 23:05, 1 hour 8 minutes ago DeFi Technologies Inc. Announces First Quarter 2026 Financial Results with Revenue of $11.2 Million, Net Income of $4.9 Million, and Strong Balance Sheet
Published on 05/14/2026 at 19:55, 4 hours 18 minutes ago Gastech 2026 to convene global energy leaders in Bangkok as Asia accelerates demand, LNG investment and system transformation
Published on 05/14/2026 at 19:30, 4 hours 43 minutes ago FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction
Published on 05/14/2026 at 19:18, 4 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/14/2026 at 09:03, 15 hours 10 minutes ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 6 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day 6 hours ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires